Dataset Viewer
mmwr_week_end
stringclasses 53
values | pathogen
stringclasses 9
values | n_enrolled
int64 209
611
| pct_positive
float64 0
50.3
| mmwr_week
int64 1
52
| footnote
float64 |
|---|---|---|---|---|---|
03/16/2024 | Adenovirus | 424 | 6.39 | 11 | null |
03/16/2024 | EV-D68 | 424 | 0 | 11 | null |
03/16/2024 | HCOV | 424 | 7.62 | 11 | null |
03/16/2024 | HMPV | 424 | 9.09 | 11 | null |
03/16/2024 | Influenza | 424 | 18.18 | 11 | null |
03/16/2024 | PIV | 424 | 5.16 | 11 | null |
03/16/2024 | RSV | 424 | 4.21 | 11 | null |
03/16/2024 | RV/EV | 424 | 26.54 | 11 | null |
03/16/2024 | SARS-CoV-2 | 424 | 2.46 | 11 | null |
03/23/2024 | Adenovirus | 450 | 4.35 | 12 | null |
03/23/2024 | EV-D68 | 450 | 0 | 12 | null |
03/23/2024 | HCOV | 450 | 5.95 | 12 | null |
03/23/2024 | HMPV | 450 | 11.44 | 12 | null |
03/23/2024 | Influenza | 450 | 10.98 | 12 | null |
03/23/2024 | PIV | 450 | 7.55 | 12 | null |
03/23/2024 | RSV | 450 | 2.56 | 12 | null |
03/23/2024 | RV/EV | 450 | 29.75 | 12 | null |
03/23/2024 | SARS-CoV-2 | 450 | 1.6 | 12 | null |
03/30/2024 | Adenovirus | 420 | 5.83 | 13 | null |
03/30/2024 | EV-D68 | 420 | 0 | 13 | null |
03/30/2024 | HCOV | 420 | 7.52 | 13 | null |
03/30/2024 | HMPV | 420 | 13.35 | 13 | null |
03/30/2024 | Influenza | 420 | 12.14 | 13 | null |
03/30/2024 | PIV | 420 | 7.28 | 13 | null |
03/30/2024 | RSV | 420 | 2.91 | 13 | null |
03/30/2024 | RV/EV | 420 | 29.13 | 13 | null |
03/30/2024 | SARS-CoV-2 | 420 | 0.97 | 13 | null |
04/06/2024 | Adenovirus | 487 | 4.26 | 14 | null |
04/06/2024 | EV-D68 | 487 | 0.36 | 14 | null |
04/06/2024 | HCOV | 487 | 6.81 | 14 | null |
04/06/2024 | HMPV | 487 | 14.04 | 14 | null |
04/06/2024 | Influenza | 487 | 11.91 | 14 | null |
04/06/2024 | PIV | 487 | 9.15 | 14 | null |
04/06/2024 | RSV | 487 | 3.12 | 14 | null |
04/06/2024 | RV/EV | 487 | 31.28 | 14 | null |
04/06/2024 | SARS-CoV-2 | 487 | 1.49 | 14 | null |
04/13/2024 | Adenovirus | 410 | 5.01 | 15 | null |
04/13/2024 | EV-D68 | 410 | 0 | 15 | null |
04/13/2024 | HCOV | 410 | 4.01 | 15 | null |
04/13/2024 | HMPV | 410 | 14.79 | 15 | null |
04/13/2024 | Influenza | 410 | 7.77 | 15 | null |
04/13/2024 | PIV | 410 | 10.03 | 15 | null |
04/13/2024 | RSV | 410 | 1.51 | 15 | null |
04/13/2024 | RV/EV | 410 | 31.83 | 15 | null |
04/13/2024 | SARS-CoV-2 | 410 | 1.25 | 15 | null |
04/20/2024 | Adenovirus | 412 | 4.5 | 16 | null |
04/20/2024 | EV-D68 | 412 | 1.2 | 16 | null |
04/20/2024 | HCOV | 412 | 3.25 | 16 | null |
04/20/2024 | HMPV | 412 | 13.75 | 16 | null |
04/20/2024 | Influenza | 412 | 3.75 | 16 | null |
04/20/2024 | PIV | 412 | 11 | 16 | null |
04/20/2024 | RSV | 412 | 1.26 | 16 | null |
04/20/2024 | RV/EV | 412 | 35.75 | 16 | null |
04/20/2024 | SARS-CoV-2 | 412 | 2.75 | 16 | null |
04/27/2024 | Adenovirus | 397 | 7.59 | 17 | null |
04/27/2024 | EV-D68 | 397 | 0.42 | 17 | null |
04/27/2024 | HCOV | 397 | 1.57 | 17 | null |
04/27/2024 | HMPV | 397 | 12.57 | 17 | null |
04/27/2024 | Influenza | 397 | 1.83 | 17 | null |
04/27/2024 | PIV | 397 | 9.95 | 17 | null |
04/27/2024 | RSV | 397 | 1.31 | 17 | null |
04/27/2024 | RV/EV | 397 | 40.58 | 17 | null |
04/27/2024 | SARS-CoV-2 | 397 | 3.4 | 17 | null |
05/04/2024 | Adenovirus | 450 | 4.95 | 18 | null |
05/04/2024 | EV-D68 | 450 | 0.37 | 18 | null |
05/04/2024 | HCOV | 450 | 4.5 | 18 | null |
05/04/2024 | HMPV | 450 | 15.09 | 18 | null |
05/04/2024 | Influenza | 450 | 1.13 | 18 | null |
05/04/2024 | PIV | 450 | 10.36 | 18 | null |
05/04/2024 | RSV | 450 | 0.45 | 18 | null |
05/04/2024 | RV/EV | 450 | 37.16 | 18 | null |
05/04/2024 | SARS-CoV-2 | 450 | 1.35 | 18 | null |
05/11/2024 | Adenovirus | 390 | 4.71 | 19 | null |
05/11/2024 | EV-D68 | 390 | 1.3 | 19 | null |
05/11/2024 | HCOV | 390 | 2.36 | 19 | null |
05/11/2024 | HMPV | 390 | 13.09 | 19 | null |
05/11/2024 | Influenza | 390 | 3.4 | 19 | null |
05/11/2024 | PIV | 390 | 11.78 | 19 | null |
05/11/2024 | RSV | 390 | 1.32 | 19 | null |
05/11/2024 | RV/EV | 390 | 33.51 | 19 | null |
05/11/2024 | SARS-CoV-2 | 390 | 0.79 | 19 | null |
05/18/2024 | Adenovirus | 396 | 5.41 | 20 | null |
05/18/2024 | EV-D68 | 396 | 1.72 | 20 | null |
05/18/2024 | HCOV | 396 | 1.8 | 20 | null |
05/18/2024 | HMPV | 396 | 11.6 | 20 | null |
05/18/2024 | Influenza | 396 | 2.84 | 20 | null |
05/18/2024 | PIV | 396 | 14.18 | 20 | null |
05/18/2024 | RSV | 396 | 1.06 | 20 | null |
05/18/2024 | RV/EV | 396 | 35.31 | 20 | null |
05/18/2024 | SARS-CoV-2 | 396 | 0.77 | 20 | null |
05/25/2024 | Adenovirus | 393 | 8.03 | 21 | null |
05/25/2024 | EV-D68 | 393 | 1.18 | 21 | null |
05/25/2024 | HCOV | 393 | 1.81 | 21 | null |
05/25/2024 | HMPV | 393 | 12.18 | 21 | null |
05/25/2024 | Influenza | 393 | 1.55 | 21 | null |
05/25/2024 | PIV | 393 | 11.66 | 21 | null |
05/25/2024 | RSV | 393 | 2.42 | 21 | null |
05/25/2024 | RV/EV | 393 | 33.42 | 21 | null |
05/25/2024 | SARS-CoV-2 | 393 | 1.81 | 21 | null |
06/01/2024 | Adenovirus | 340 | 5.07 | 22 | null |
End of preview. Expand
in Data Studio
Pathogen Detections Among Enrolled Children in the New Vaccine Surveillance Network (NVSN), Acute Respiratory Illnesses (ARI), 12 Month Rolling Period
Description
Percent positivity of 9 viral pathogens, and enrollment counts of children with ARI by week for the past 12 months (rolling x-axis).
Dataset Details
- Publisher: Centers for Disease Control and Prevention
- Temporal Coverage: 12 month rolling period
- Geographic Coverage: United States
- Last Modified: 2025-04-02
- Contact: CDC-INFO ([email protected])
Source
Original data can be found at: https://www.cdc.gov/surveillance/nvsn/index.html
Usage
You can load this dataset using:
from datasets import load_dataset
dataset = load_dataset('HHS-Official/pathogen-detections-among-enrolled-children-in-the')
License
This dataset is licensed under https://www.usa.gov/government-works
- Downloads last month
- 33